The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer

1994 ◽  
Vol 34 (5) ◽  
pp. 439-443
Author(s):  
Bente S�rensen ◽  
Lars Bastholt ◽  
Mansoor Raza Mirza ◽  
Susanne B. Gjedde ◽  
Preben Jakobsen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Metastatic Breast ◽  
High Dose

The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer

1994 ◽  
Vol 34 (5) ◽  
pp. 439-443 ◽  
Author(s):  
Bente S�rensen ◽  
Lars Bastholt ◽  
Mansoor Raza Mirza ◽  
Susanne B. Gjedde ◽  
Preben Jakobsen ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Metastatic Breast ◽  
High Dose

scholarly journals A Phase I Study of Pemetrexed (ALIMTA) and Cyclophosphamide in Patients with Locally Advanced or Metastatic Breast Cancer

2006 ◽  
Vol 12 (23) ◽  
pp. 7071-7078 ◽  
Author(s):  
Christian Dittrich ◽  
Lubos Petruzelka ◽  
Pavel Vodvarka ◽  
Margit Gneist ◽  
Filip Janku ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Locally Advanced ◽  
Metastatic Breast

scholarly journals Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients

2016 ◽  
Vol 16 (2) ◽  
pp. 82-86 ◽  
Author(s):  
Winston W. Tan ◽  
Jacob B. Allred ◽  
Alvaro Moreno-Aspitia ◽  
Donald W. Northfelt ◽  
James N. Ingle ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Phase I Study ◽  
Metastatic Breast ◽  
Breast Cancer Patients

Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience

1999 ◽  
Vol 54 (3) ◽  
pp. 225-233 ◽  
Author(s):  
Massimo Cristofanilli ◽  
Frankie Ann Holmes ◽  
Laura Esparza ◽  
Vicente Valero ◽  
Aman U. Buzdar ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Metastatic Breast ◽  
Cancer Center ◽  
High Dose

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

2017 ◽  
Vol 164 (2) ◽  
pp. 359-369 ◽  
Author(s):  
Cornelia von Hagens ◽  
Ingeborg Walter-Sack ◽  
Maren Goeckenjan ◽  
Julia Osburg ◽  
Brigitte Storch-Hagenlocher ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Metastatic Breast

370 Taxol® (paclitaxel) and farmorubicin® (epirubicin) in metastatic breast cancer (MBC): Preliminary results of a phase I study

1995 ◽  
Vol 31 ◽  
pp. S80-S81
Author(s):  
M. Spielmann ◽  
G. Catimel ◽  
L. Kayitalire ◽  
P. Pouillart ◽  
A. Dumortier ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Metastatic Breast ◽  
Preliminary Results
Sign in / Sign up

Export Citation Format

Share Document